This inventor holds 2 USPTO granted patents. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Naomi Moldavski: Innovator in Pharmaceutical Microparticles
Introduction
Naomi Moldavski is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a focus on microparticles, her work has the potential to enhance the efficacy of various medications.
Latest Patents
Naomi Moldavski holds 2 patents that showcase her expertise in pharmaceutical formulations. Her latest patents include "Risperidone microparticles formed by sublimation," which provides microparticles of active pharmaceutical ingredients, drug delivery vehicles comprising the same, and methods for making them. Another notable patent is "Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them," which details the preparation of microparticles by removing a sublimable carrier from a solid solution of active pharmaceutical ingredients.
Career Highlights
Naomi Moldavski is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her work at Teva has allowed her to focus on innovative drug delivery technologies that can improve patient outcomes.
Collaborations
Throughout her career, Naomi has collaborated with esteemed colleagues such as E Itzhak Lerner and Moshe Flashner-Barak. These collaborations have further enriched her research and development efforts in the pharmaceutical sector.
Conclusion
Naomi Moldavski is a trailblazer in the field of pharmaceutical innovations, with her patents paving the way for advancements in drug delivery systems. Her contributions are vital to the ongoing evolution of effective medication therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
